Visiting Fellow, Centre on Global Health Security
Contact information
+44 (0)20 7314 3614

Summary

Dr Ioannou is a veterinary surgeon and a visiting fellow of the Centre on Global Health Security at Chatham House. Since 2006 she has been working for the European Medicines Agency in London on the regulation of veterinary medicines. She is primarily involved in the regulation of novel vaccines and immunological products and has worked extensively on vaccines authorised under emergency circumstances and with accelerated timetables. She has an interest in the potential role of vaccines in combating antimicrobial resistance. She has previously worked for the Food and Veterinary Office (FVO) of the European Commission as well as Pfizer Animal Health, where she worked on the development of new veterinary vaccines. Between 2001-02 she was based in the Foot and Mouth Disease (FMD) Crisis Control Centre in Cumbria, assisting DEFRA in combating the FMD outbreak. She is a graduate of the Veterinary Medicine School of Aristotle University of Thessaloniki, Greece, and has completed further studies in the area of European policies and economy.

Expertise

  • Veterinary vaccines
  • Regulation of veterinary medicines
  • European policies on animal/public health
  • Interface of animal and human health (One Health)

Experience

2006 - presentProject Manager, Veterinary Medicines Unit, European Medicines Agency
2004-06Policy Official, Food and Veterinary Office (FVO), European Commission
2003-04Manager, Veterinary Medicine Research and Development, Pfizer Animal Health 
2001-02Team Leader, Foot and Mouth Disease Crisis Centre Cumbria, DEFRA  

 

Broadcast experience

Some

Languages

  • English
  • Greek
  • German (not for broadcast)
  • Accelerating Vaccine Development and deployment: report of a Royal Society satellite meeting, Journal:  Phil. Trans R. Soc. B ,Volume:  366 ,Pages:  2841-2849,  (speaker)
  • Efficacy of an intranasal modified live bovine respiratory syncytial virus  and  temperature-sensitive parainfluenza type 3 virus (PI3V) vaccine in 3-week-old calves and experimentally challenged with PI3V, The Veterinary Journal, 11/2007; 179(1):101-8